Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2272 studies found for:    pancreatic cancer
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Ipilimumab;   Biological: Pancreatic Cancer Vaccine
2 Completed Studying Biomarkers in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Genetic: protein analysis;   Other: laboratory biomarker analysis
3 Recruiting A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer
Conditions: Pancreatic Cancer;   Hypoxia
Intervention:
4 Completed Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Other: laboratory biomarker analysis
5 Recruiting Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: GAX - Gemcitabine, Abraxane and Xeloda
6 Recruiting Neoadjuvant/Adjuvant GVAX Pancreas Vaccine (With CY) With or Without Nivolumab Trial for Surgically Resectable Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Cyclophosphamide;   Biological: GVAX pancreatic cancer;   Drug: Nivolumab
7 Active, not recruiting Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
Condition: Pancreatic Cancer
Interventions: Biological: GVAX pancreatic cancer vaccine;   Drug: cyclophosphamide
8 Active, not recruiting Vaccine Therapy in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
Condition: Pancreatic Cancer
Intervention: Biological: allogenic GM-CSF plasmid-transfected pancreatic tumor cell vaccine
9 Completed Vaccine Study for Surgically Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute(R)-Pancreatic Cancer Vaccine
10 Active, not recruiting Stool Testing for Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
11 Terminated Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute(R)-Pancreatic Cancer Vaccine
12 Active, not recruiting Pancreatic Cancer Genetic Epidemiology (PACGENE) Study
Condition: Pancreatic Cancer
Intervention: Behavioral: Questionnaire
13 Completed
Has Results
Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Cetuximab;   Biological: Pancreatic tumor vaccine;   Drug: Cyclophosphamide
14 Withdrawn HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Procedure: interventional therapy
15 Unknown  Computer Tools for Improving Early Diagnosis and Treatment in Healthy Volunteers or Patients With Pancreatic Cancer or Who Are At Risk For Pancreatic Cancer or Who Have a Noncancer Pancreatic Disorder
Condition: Pancreatic Cancer
Interventions: Other: medical chart review;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: biopsy
16 Completed Tarceva and Capecitabine for Pancreatic Cancer
Conditions: Pancreatic Cancer;   Neoplasm Metastasis
Interventions: Drug: Capecitabine;   Drug: OSI-774
17 Recruiting The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome
Condition: Pancreatic Cancer
Interventions: Drug: Gadobutrol;   Drug: [F-18]HX4;   Drug: Gemcitabine;   Radiation: Radiotherapy;   Procedure: Pancreaticoduodenectomy
18 Completed Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis
Conditions: Pancreatic Cancer;   Precancerous Condition
Intervention:
19 Completed
Has Results
BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Dose level 1;   Drug: Dose level 2/MTD;   Drug: Dose level 3
20 Recruiting Exceptional Responders With Pancreatic Cancer to Chemotherapy
Condition: Pancreatic Neoplasms
Intervention: Drug: Standard of care chemotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years